
Bionano Genomics is a medical instruments & supplies business based in the US. Bionano Genomics shares (BNGO) are listed on the NASDAQ and all prices are listed in US Dollars. Bionano Genomics employs 299 staff and has a trailing 12-month revenue of around $25.9 million.
How to buy Bionano Genomics stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – BNGO. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Bionano Genomics stock price (NASDAQ: BNGO)
Use our graph to track the performance of BNGO stocks over time.Bionano Genomics shares at a glance
Latest market close | $1.85 |
---|---|
52-week range | $1.16 - $4.35 |
50-day moving average | $1.95 |
200-day moving average | $1.98 |
Wall St. target price | $6.70 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.33 |
Buy Bionano Genomics stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Bionano Genomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bionano Genomics price performance over time
Historical closes compared with the close of $1.85 from 2023-01-27
1 week (2023-01-23) | -3.65% |
---|---|
1 month (2022-12-30) | 26.71% |
3 months (2022-10-27) | -13.35% |
6 months (2022-07-26) | 9.47% |
1 year (2022-01-28) | -4.64% |
---|---|
2 years (2021-01-29) | -83.26% |
3 years (2020-01-30) | 69.72% |
5 years (2018-01-26) | N/A |
Bionano Genomics financials
Revenue TTM | $25.9 million |
---|---|
Gross profit TTM | $3.9 million |
Return on assets TTM | -22.17% |
Return on equity TTM | -37.5% |
Profit margin | 0% |
Book value | $0.95 |
Market capitalisation | $546.3 million |
TTM: trailing 12 months
Bionano Genomics share dividends
We're not expecting Bionano Genomics to pay a dividend over the next 12 months.
Bionano Genomics share price volatility
Over the last 12 months, Bionano Genomics's shares have ranged in value from as little as $1.16 up to $4.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bionano Genomics's is 2.2531. This would suggest that Bionano Genomics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Bionano Genomics overview
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California. .
Bionano Genomics in the news
Are Medical Stocks Lagging Bionano Genomics (BNGO) This Year?
Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies
Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies
Frequently asked questions
What percentage of Bionano Genomics is owned by insiders or institutions?Currently 1.869% of Bionano Genomics shares are held by insiders and 27.604% by institutions. How many people work for Bionano Genomics?
Latest data suggests 299 work at Bionano Genomics. When does the fiscal year end for Bionano Genomics?
Bionano Genomics's fiscal year ends in December. Where is Bionano Genomics based?
Bionano Genomics's address is: 9540 Towne Centre Drive, San Diego, CA, United States, 92121 What is Bionano Genomics's ISIN number?
Bionano Genomics's international securities identification number is: US09075F1075 What is Bionano Genomics's CUSIP number?
Bionano Genomics's Committee on Uniform Securities Identification Procedures number is: 09075F206
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert